Skip to main content
. 2021 Jun 15;16:278. doi: 10.1186/s13023-021-01902-5

Table 1.

Clinical features of 10 probands

ID Sex Diagnosis Initial sympton NYS Age of onset (y) Age at visit (y) BCVA (decimal) OD/OS ERG (scotopic/photopic) VF
F1-III:4 M RP, HM Night blindness N 39 46 0.4/0.6 NA Constricted
F2-III:3 M RP, MC Night blindness. Central vision impairment N  < 1 27 0.1/0.1 Both severely reduced NA
F3-III:5 F RP Night blindness N 20 51 LP NA NA
F4-III:4 F RP Night blindness N 20 60 HM/HM Both severely reduced NA
F5-III:1 M RP Night blindness N 14 34 0.5/0.6 Both severely reduced Constricted
F6-III:1 F RP Night blindness N 6 23 0.8/0.6 Severely reduced/slightly reduced Constricted
F7-III:4 M CORD, POAG Central vision impairment N 40 45 CF at 1 m/0.02 Both severely reduced Central scotoma
F8-III:5 F CORD Central vision impairment N 32 43 CF at 40 cm/0.01 Both severely reduced, greater loss in cone Central scotoma
F9-III:2 M BCD Night blindness N 43 44 0.6/0.8 Severely reduced/slightly reduced Constricted
F10-III:1 F LCA Vision impairment Y  < 1 29 HM/HM Extinguished NA

NYS, Nystagmus; M, male; F, female; RP, retinitis pigmentosa; HM, high myopia; MC, coloboma-like lesions in macula; CORD, cone and rod dystrophy; POAG, primary open-angle glaucoma; BCD, Bietti crystalline dystrophy; BCVA, best corrected visual acuity; OD, right eye; OS, left eye; VF, visual field; ERGs, Electroretinograms; NA, not available